0001358403-19-000007.txt : 20190104 0001358403-19-000007.hdr.sgml : 20190104 20190104160207 ACCESSION NUMBER: 0001358403-19-000007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190102 FILED AS OF DATE: 20190104 DATE AS OF CHANGE: 20190104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Spencer David M. CENTRAL INDEX KEY: 0001627362 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36783 FILM NUMBER: 19509946 MAIL ADDRESS: STREET 1: C/O BELLICUM PHARMACEUTICALS, INC. STREET 2: 2130 W. HOLCOMBE BLVD., STE. 800 CITY: HOUSTON STATE: TX ZIP: 77030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001358403 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201450200 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77030 BUSINESS PHONE: (832) 384-1100 MAIL ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77030 FORMER COMPANY: FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060405 4 1 wf-form4_154663570769533.xml FORM 4 X0306 4 2019-01-02 0 0001358403 BELLICUM PHARMACEUTICALS, INC BLCM 0001627362 Spencer David M. C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030 0 1 0 0 Chief Technology Officer Common Stock 2019-01-02 4 M 0 2500 A 92439 D Common Stock 2019-01-02 4 F 0 942 3.33 D 91497 D Common Stock 2019-01-03 4 M 0 1562 A 93059 D Common Stock 2019-01-03 4 F 0 589 3.20 D 92470 D Restricted Stock Units 2019-01-02 4 M 0 2500 0 D Common Stock 2500.0 7500 D Restricted Stock Units 2019-01-03 4 M 0 1562 0 D Common Stock 1562.0 3125 D Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer common stock. Represents the number of shares withheld by and surrendered to the Issuer on January 2, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 2, 2018 for 10,000 shares. Represents the number of shares withheld by and surrendered to the Issuer on January 3, 2019, to satisfy tax withholding obligations that arose in connection with the vesting of the RSUs granted to the reporting person on January 3, 2017 for 6,250 shares. The RSUs vest in four equal annual installments beginning on January 2, 2019. The RSUs vest in four equal annual installments beginning on January 3, 2018. /s/ Rosemary Y. Williams, Attorney-in-Fact 2019-01-04